Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06443359 · ClinicalTrials.gov registry record · NA
Hypofractionated Regional Nodal Irradiation in Breast Cancer
A NA study of Breast Cancer, sponsored by Corewell Health East.
- Active
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 3
- Study locations
NCT06443359 is a NA study of Breast Cancer that is active but no longer recruiting, run by Corewell Health East. The registered enrollment target is 56 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT06443359, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by Corewell Health East.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a prospective clinical trial designed to evaluate the efficacy and safety of hypofractionated regional nodal irradiation in breast cancer patients. After enrollment, participants will be stratified into 2 Groups based on the extent of axillary surgery. Participants will complete activities and assessments at baseline, and after completion of treatment at 1-2 weeks, 3 months, 6 months, 1 year, 2 year, and 3 years following completion of treatment.
Conditions Studied
Interventions
- RADIATION hypofractionated radiation
Study Locations (3)
Michigan
- Corewell Health Dearborn Hospital - Dearborn
- Corewell Health William Beaumont University Hospital - Royal Oak
- Corewell Health Beaumont Troy Hospital - Troy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2018-11-13 |
| Est. Completion | 2027-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06443359
The ClinicalTrials.gov registry entry for NCT06443359 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which hypofractionated radiation is the first listed.
NCT06443359 reports 3 study locations spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT06443359 about?
NCT06443359 is a clinical study titled "Hypofractionated Regional Nodal Irradiation in Breast Cancer". This is a prospective clinical trial designed to evaluate the efficacy and safety of hypofractionated regional nodal irradiation in breast cancer patients. After enrollment, participants will be stratified into 2 Groups based on the extent of axillary surgery. Participants will complete activities a...
What is the current status of trial NCT06443359?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2018-11-13. Estimated completion is 2027-07.
What conditions does trial NCT06443359 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT06443359?
The interventions under investigation include: hypofractionated radiation (RADIATION).
Who is sponsoring clinical trial NCT06443359?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06443359 being conducted?
This trial has 3 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.